Literature DB >> 2166981

Monoclonal antibody to immediate early protein encoded by varicella-zoster virus gene 62.

B Forghani1, R Mahalingam, A Vafai, J W Hurst, K W Dupuis.   

Abstract

Monoclonal antibodies (mAbs) were prepared against varicella-zoster virus (VZV)-infected cell proteins, and 10 mAbs which reacted with nuclear antigens were selected. These mAbs recognized a major 175-180 kDa and three minor VZV-specific phosphoprotein species. Immunofluorescence staining of VZV-infected cells showed that the 175-180 kDa protein was synthesized within 6 h after infection. The synthesis of this protein was inhibited by cycloheximide (CH); however, reversal of CH treatment and addition of actinomycin D (ActD) resulted in the synthesis of the 175-180 kDa protein. To determine whether the 175-180 kDa protein seen in the infected cells is encoded by VZV immediate early (IE) gene 62, the predicted open reading frames of VZV genes 61 and 62 were cloned into pGEM transcription vectors. RNA was transcribed from each gene, translated in vitro and immunoprecipitated with a mAb which recognizes a major 175-180 kDa and three minor proteins. The reactivity of the in vitro translation products encoded by gene 62 with this mAb suggested that the 175-180 kDa protein is encoded by VZV IE gene 62.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2166981     DOI: 10.1016/0168-1702(90)90023-5

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  19 in total

1.  Comparison of biotinylated DNA and RNA probes for rapid detection of varicella-zoster virus genome by in situ hybridization.

Authors:  B Forghani; G J Yu; J W Hurst
Journal:  J Clin Microbiol       Date:  1991-03       Impact factor: 5.948

2.  Phosphorylation of the varicella-zoster virus (VZV) major transcriptional regulatory protein IE62 by the VZV open reading frame 66 protein kinase.

Authors:  Amie J Eisfeld; Stephanie E Turse; Sara A Jackson; Edwina C Lerner; Paul R Kinchington
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

3.  Phosphorylation and nuclear localization of the varicella-zoster virus gene 63 protein.

Authors:  D Stevenson; M Xue; J Hay; W T Ruyechan
Journal:  J Virol       Date:  1996-01       Impact factor: 5.103

4.  The cellular transcription factor USF cooperates with varicella-zoster virus immediate-early protein 62 to symmetrically activate a bidirectional viral promoter.

Authors:  J L Meier; X Luo; M Sawadogo; S E Straus
Journal:  Mol Cell Biol       Date:  1994-10       Impact factor: 4.272

5.  Nuclear localization signals of varicella zoster virus ORF4.

Authors:  Yizhong Huang; Jie Zhang; Mohammed Abo Halawa; Shanglong Yao
Journal:  Virus Genes       Date:  2014-01-08       Impact factor: 2.332

6.  Transcriptional mapping of the varicella-zoster virus regulatory genes encoding open reading frames 4 and 63.

Authors:  P R Kinchington; J P Vergnes; P Defechereux; J Piette; S E Turse
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

7.  Varicella-zoster virus gene 63 encodes an immediate-early protein that is abundantly expressed during latency.

Authors:  S Debrus; C Sadzot-Delvaux; A F Nikkels; J Piette; B Rentier
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

8.  Mutational analysis of varicella-zoster virus major immediate-early protein IE62.

Authors:  L Baudoux; P Defechereux; S Schoonbroodt; M P Merville; B Rentier; J Piette
Journal:  Nucleic Acids Res       Date:  1995-04-25       Impact factor: 16.971

9.  Downregulation of varicella-zoster virus (VZV) immediate-early ORF62 transcription by VZV ORF63 correlates with virus replication in vitro and with latency.

Authors:  Susan E Hoover; Randall J Cohrs; Zoila G Rangel; Donald H Gilden; Peter Munson; Jeffrey I Cohen
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

10.  The transcriptional regulatory proteins encoded by varicella-zoster virus open reading frames (ORFs) 4 and 63, but not ORF 61, are associated with purified virus particles.

Authors:  P R Kinchington; D Bookey; S E Turse
Journal:  J Virol       Date:  1995-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.